NORTH STAR INVESTMENT MANAGEMENT CORP. – BioCryst Pharmaceuticals, Inc. Transaction History
NORTH STAR INVESTMENT MANAGEMENT CORP. portfolio value:
$5.56M
portfolio value
NORTH STAR INVESTMENT MANAGEMENT CORP. quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 893K | $12.6 | 441.9K | |
| Q2 2022 | share | Decrease | -0.34% | -1.5K shares | -2.53M | $10.58 | 441.9K |
| Q1 2022 | share | Decrease | -1.42% | -6.4K shares | 980K | $16.26 | 443.4K |
| Q4 2021 | share | Increase | +1.56% | 6.9K shares | -134K | $13.79 | 449.8K |
| Q3 2021 | share | Increase | +1.42% | 6.21K shares | -540K | $14.37 | 442.9K |
| Q2 2021 | share | Increase | +0.21% | 900 shares | 2.47M | $15.81 | 436.69K |
| Q1 2021 | share | Increase | +45.17% | 135.6K shares | 2.19M | $10.17 | 435.79K |
| Q4 2020 | share | Increase | +71.54% | 125.19K shares | 1.63M | $7.45 | 300.19K |
| Q3 2020 | share | Increase | +337.50% | 135K shares | 410K | $3.44 | 175K |
| Q2 2020 | share | Increase | 0.00% | 40K shares | 191K | $4.76 | 40K |